Crossmark

Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm

Published Online: 2020-08-06

Authors

Guo, Chuang https://orcid.org/0000-0002-3912-0793
Li, Bin

Ma, Huan

Wang, Xiaofang

Cai, Pengfei

Yu, Qiaoni

Zhu, Lin

Jin, Liying

Jiang, Chen

Fang, Jingwen

Liu, Qian

Zong, Dandan

Zhang, Wen

Lu, Yichen

Li, Kun https://orcid.org/0000-0001-6550-4937
Gao, Xuyuan

Fu, Binqing

Liu, Lianxin

Ma, Xiaoling

Weng, Jianping

Wei, Haiming https://orcid.org/0000-0002-1675-6502
Jin, Tengchuan https://orcid.org/0000-0002-1395-188X
Lin, Jun https://orcid.org/0000-0001-7087-6540
Qu, Kun https://orcid.org/0000-0002-5555-8437
License Information

Text and Data Mining valid from 2020-08-06

Version of Record valid from 2020-08-06
More Information

Article History

Received: 17 April 2020

Accepted: 21 July 2020

First Online: 6 August 2020

Competing interests

: Jingwen Fang is the chief executive officer of HanGen Biotech. The other authors declare no competing interests.

Document is current